Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ABT | US
-1.35
-1.46%
Healthcare
Medical Devices
30/06/2024
24/04/2026
91.13
92.15
92.64
91.06
Abbott Laboratories together with its subsidiaries discovers develops manufactures and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products Diagnostic Products Nutritional Products and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency irritable bowel syndrome or biliary spasm intrahepatic cholestasis or depressive symptoms gynecological disorder hormone replacement therapy dyslipidemia hypertension hypothyroidism Ménière's disease and vestibular vertigo pain fever inflammation and migraine as well as provides anti-infective clarithromycin influenza vaccine and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay clinical chemistry hematology and transfusion; molecular diagnostics systems that automate the extraction purification and preparation of DNA and RNA from patient samples as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV SARS-CoV-2 influenza A and B RSV and strep A; cardiometabolic test systems; drug and alcohol test and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management electrophysiology heart failure vascular and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago Illinois.
View LessLow 6-Month Volatility (<30%)
Largecap (10B - 200B USD)
Low Market Beta (-0.4 to 0.8)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
Weak P/E, and PEG ratio indicator
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
35.6%1 month
27.9%3 months
24.0%6 months
25.2%36.29
22.88
5.22
0.38
0.20
23.63
5.16
4.31
10.64B
158.56B
158.56B
1.87
17.58
14.60
4.90
14.44
2.44
0.68
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
12.05
Range1M
15.26
Range3M
26.10
Rel. volume
1.16
Price X volume
1.15B
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Intuitive Surgical Inc | ISRG | Medical Instruments & Supplies | 482.22 | 171.36B | 0.71% | 83.92 | 0.00% |
| Stryker Corporation | SYK | Medical Devices | 327.51 | 124.81B | -0.65% | 41.25 | 64.49% |
| Medtronic plc | MDT | Medical Devices | 83.32 | 106.87B | -0.56% | 31.06 | 58.12% |
| Boston Scientific Corporation | BSX | Medical Devices | 62.07 | 91.41B | -5.51% | 71.60 | 53.68% |
| Edwards Lifesciences Corporation | EW | Medical Devices | 84.15 | 50.69B | 5.56% | 27.67 | 9.32% |
| Becton Dickinson and Company | BDX | Medical Instruments & Supplies | 152.14 | 43.97B | -1.75% | 48.75 | 74.70% |
| Assisted Living Concepts LLC | ALC | Medical Instruments & Supplies | 75.8 | 37.39B | -0.08% | 42.86 | 24.31% |
| ResMed Inc | RMD | Medical Instruments & Supplies | 219.85 | 32.27B | 0.15% | 34.68 | 17.97% |
| West Pharmaceutical Services Inc | WST | Medical Instruments & Supplies | 306.16 | 22.21B | -1.14% | 41.66 | 12.19% |
| STERIS plc | STE | Medical Instruments & Supplies | 221.8 | 21.87B | -0.77% | 40.01 | 39.10% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Carrier Global Corporation | CARR | Building Products & Equipment | 60.97 | 55.04B | -0.93% | 21.69 | 100.40% |
| CBRE Group Inc | CBRE | Real Estate Services | 148.29 | 45.44B | -0.68% | 42.32 | 79.63% |
| PPL Corporation | PPL | Building Products & Equipment | 38.75 | 28.59B | 0.54% | 28.90 | 114.80% |
| KE Holdings Inc | BEKE | Real Estate Services | 16.18 | 20.57B | 2.41% | 42.20 | 28.64% |
| Jones Lang LaSalle Incorporated | JLL | Real Estate Services | 338.56 | 16.07B | 0.28% | 33.62 | 58.74% |
| CoStar Group Inc | CSGP | Real Estate Services | 36.44 | 14.93B | -2.51% | 152.40 | 14.68% |
| Avery Dennison Corporation | AVY | Building Products & Equipment | 165.5 | 13.33B | -1.15% | 27.93 | 140.74% |
| Zillow Group Inc | ZG | Real Estate Services | 45.63 | 10.91B | 2.54% | n/a | 40.19% |
| Brookfield Property Partners L.P | BPYPP | Real Estate Services | 16.25 | 10.74B | -1.12% | 7.95 | 866.10% |
| Zillow Group Inc | Z | Real Estate Services | 45.41 | 10.51B | 2.04% | n/a | 40.19% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 23.63 | 46.09 | Cheaper |
| Ent. to Revenue | 5.16 | 14.34 | Cheaper |
| PE Ratio | 36.29 | 30.41 | Par |
| Price to Book | 5.22 | 6.21 | Par |
| Dividend Yield | 1.87 | 1.78 | Par |
| Std. Deviation (3M) | 23.96 | 64.12 | Lower Risk |
| Debt to Equity | 0.38 | -145.53 | Expensive |
| Debt to Assets | 0.20 | 0.35 | Cheaper |
| Market Cap | 158.56B | 9.70B | Market Leader |